“Motley Fool CEO Tom Gardner Reveals 8 Stocks He'd Buy Now”
AI summary · Medline has fallen almost 25% since his recommendation, which he largely blames on private-market holders selling while long-term investors buy publicly; he sees that as promising. At its current valuation, he expects 11-15% annual returns over five years from this well-managed medical-supplies giant.
The next company is Medline, another company that has gone public with a large private shareholder actively selling its stake in the public markets. For me, this is unlikely. So again, a second company is down almost 25% since I recommended it.
Medline , and its stock exchange symbol is MDLN. But again, in this case, private market shareholders are selling, while large and reliable long-term investors such as Fidelity, T.
Rowe Price, Baillie Gifford, and Invesco are buying shares in the public markets. This is a promising development for me in my assessment of the company.